FDAThe Side Effects of Inequality: How Lack of Diversity in Clinical Trials Affects Drug Effectiveness and SafetyDaphne Berryhill
FDAMakary’s “Blind Spots” Offers Big Ideas — But Can He Deliver as FDA Commissioner?Suzanne B. Robotti